Why the GWPH Stock Price Soared 130% Today and What's Next
March 14, 2016 at 11:05 AM EDT
The GWPH stock price soared more than 130% to $88.22 a share this morning (Monday) morning after GW Pharmaceuticals Plc. (Nasdaq ADR: GWPH) announced positive phase 3 study results for its investigational cannabidiol drug, Epidiolex. Epidiolex is designed to treat Dravet syndrome. Also known as severe myoclonic epilepsy of infancy (SMEI), Dravet syndrome is a type of epilepsy with often fatal seizures. Here's what else investors need to know... Tags: buy GWPH stock , GW Pharmaceuticals stock , GW pharmaceuticals stock price , GW stock price , gwph stock price , GWPH stock price today , GWPH trial , Nasdaq: GWPH To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2016 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Why the GWPH Stock Price Soared 130% Today and What's Next appeared first on Money Morning - We Make Investing Profitable .